banner

AI fraud

  • img
    Article 27-04-2026

    COA Fraud Detection Checklist

    A Certificate of Analysis (COA) is a critical quality document confirming that a product meets defined specifications before release.

    However, with the rise of counterfeit and substandard products, COA fraud has become a serious risk across pharma, chemicals, and metals.

    Why this matters

    • Counterfeit pharmaceuticals alone represent a $200B+ global problem (Source: Wikipedia)
    • In some developing markets, over 30% of medicines may be fake
    • Fake or manipulated documentation (including COAs) is a key enabler of such fraud

    This makes COA validation not just a compliance task, but a risk management function.

    A Structured Checklist on COA Fraud:

    Checkpoint Category Fraud Indicator What to Verify Risk Level Industry Insight / Data Point
    Document Authenticity Missing or inconsistent certificate number Verify unique COA ID across batches High Fake documentation often lacks traceable IDs
    No authorized signature or digital validation Check signer credentials and audit trail High COA approval is mandatory before product release (sec.gov)
    Altered or scanned-looking signatures Compare with known authorized signatories Medium Forged approvals are a common fraud pattern
    Supplier Verification Unknown or unverified lab issuing COA Cross-check lab accreditation High Weak regulatory systems increase counterfeit risks (Wikipedia)
    Mismatch between supplier and testing lab Validate third-party lab relationship High Fraud often occurs via fake third-party labs
    Data Integrity Identical test results across multiple batches Check for data duplication patterns High Repetition suggests fabricated or copied data
    Values too “perfect” (no variance) Compare with historical batch variation Medium Real-world manufacturing always shows variation
    Missing test parameters Ensure all required specs are present High COA must include all defined test procedures (ghsupplychain.org)
    Product-Level Validation Batch number mismatch Cross-check with shipment and invoice High Fraud often involves relabeling expired or fake goods
    Expiry dates overwritten or inconsistent Validate against production records High Fake drugs often carry incorrect expiry info (Wikipedia)
    Compliance Check Non-alignment with regulatory standards (FDA, ASTM, ISO) Validate required compliance fields High Regulatory gaps enable counterfeit circulation
    Missing GMP references Verify manufacturing compliance High Fraud often bypasses GMP documentation
    Testing & Results Validation Unrealistic purity levels Compare with industry benchmarks Medium Counterfeit products may misrepresent composition
    No trace of test method (HPLC, GC, etc.) Ensure method transparency High COAs must include validated testing methods (sec.gov)
    Format & Structure Analysis Inconsistent formatting across COAs Compare with previous supplier documents Medium Fraudsters often replicate formats imperfectly
    Spelling errors or inconsistent units Check for anomalies Low Red flag for manually created fake documents
    Digital Verification No QR code / blockchain / digital trace Verify authenticity digitally High Increasing shift toward traceability systems
    Behavioral Red Flags Supplier reluctance to share raw test data Request supporting lab reports High Lack of transparency often signals fraud
    Urgency in shipment without validation Apply standard QA workflow Medium Fraud often exploits time pressure

    Key Patterns Observed in COA Fraud

    1. Data Fabrication & Copy-Paste Fraud

    • Identical values across batches
    • Reused templates with minor edits

    Increasingly detectable using AI-based pattern recognition.

    2. Counterfeit Product + Fake COA Combination

    • Fake drugs or materials paired with convincing documentation
    • Often includes incorrect ingredients or no active ingredient at all

    3. Third-Party Lab Misrepresentation

    • Fake lab names or unaccredited labs
    • Misuse of legitimate lab branding

    4. Expiry & Relabeling Fraud

    • Expired materials reintroduced with altered COAs
    • Particularly common in pharma and chemicals

    How Leading Companies Are Responding

    Modern organizations are moving from manual checks → AI-driven validation:

    • Automated extraction of COA fields
    • Cross-document validation (COA vs invoice vs batch records)
    • Pattern detection (duplicate values, anomalies)
    • Supplier risk scoring

    This aligns with a broader trend: document intelligence becoming a core compliance layer

    COA fraud is no longer a rare compliance issue—it is a systemic supply chain risk tied to:

    • Counterfeit products
    • Regulatory penalties
    • Brand damage
    • Patient and customer safety

    A structured checklist like the one above helps—but scaling it requires automation.

     

     

     

     

    Read More